500 patients67,039 observations150 daysLIVE

Patient P-03475

Synthetic patientONX-7 · Day 141 · 75+ · F · baseline S20Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
5%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S20
  2. Day 14 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 18 HY-01 recommendedHydration Protocol HY-01
  4. Day 19 Patient acceptedStarted HY-01 in the companion
  5. Day 23 GI symptom burden −22% vs expectedHydration Protocol HY-01
  6. Day 29 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days
  • GI instability-15
  • Inflammatory activity-13
  • Toxicity-12
  • Nutritional resilience+9
  • Treatment adherence+3

What helped?

  • Hydration Protocol HY-01Day 18
    Result: symptom burden −22%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
6.4/10
stable · +0.2 vs previous 14 d
Stress level
Daily log
2.1/10
stable · +0.1 vs previous 14 d
Pessimism score
Daily log
3/10
worsening · +0.2 vs previous 14 d
Sleep quality
Wearable
64.7/100
improving · +6.2 vs previous 14 d
Libido
Daily log
6.3/10
worsening · -0.2 vs previous 14 d
HRV
Wearable
71.6 ms
stable · +1.9 vs previous 14 d
Toxicity
Blood
4.4/100
worsening · +4.5 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 78 from the failing basin, 29 from restoration.

Good elements to keep
  • Hydration Protocol HY-01
    intervention · steering +22
  • Protein (supports)
    perturbation · steering +10.2
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -4.8 next day
Main detractors to watch
  • Low butyrate capacity
    hidden · steering -17.5
  • FUT2 non-secretor
    hidden · steering -10.6
  • Dietary fat load
    perturbation · steering -7.9
  • Low microbial diversity
    hidden · steering -7.7
  • Dietary fat load
    detractor · GI +4.7 next day
  • Histamine load
    detractor · GI +4.5 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -4.8supporter · 95%
  • Dietary fat load
    +4.7detractor · 95%
  • Histamine load
    +4.5detractor · 95%
  • Lactose
    +4.1detractor · 95%
  • Alcohol
    -1.5no signal · 26%
  • Caffeine
    -0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 60
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Butyrate / short-chain fatty acid production 35
    • MicrobiomeButyrate capacity 27/100
  • Drug metabolism and exposure 35
    • DNADPYD *2A → slower clearance
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.4 · butyrate capacity 27/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
63 ms
Sleep
6.7 h
Steps
5,796
Resting HR
63 bpm
Daily log: GI score 13, nutritional resilience 74, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0304327%S1687
P-0300127%S04CR-01improved87
P-0315627%S0785
P-0305628%S0584
P-0307927%S1884
P-0339729%S19GI-04no change84
P-0314227%S1584
P-0346928%S1983
P-0348828%S0383
P-0322729%S0383
P-0322828%S0583
P-0327629%S1483